|
|
||||||||
Department of Pharmacology, New York Medical College, Valhalla, New York 10595
We evaluated the contribution of cytochrome
P-450 (CYP450)-dependent arachidonic
acid (AA) metabolites and prostanoids to the renal hemodynamic and
tubular effects of endothelin-1 (ET-1) in anesthetized rats. Either
ET-1 (0.3, 1.0, and 3 pmol · kg
1 · min
1)
or vehicle was infused intravenously during two to three 30-min clearance experimental periods. Only high-dose ET-1 increased mean
arterial pressure: control, 75 ± 3 mmHg vs. experimental, 84 ± 4 mmHg. A dose-dependent diuretic-natriuretic response to ET-1
occurred despite progressive declines in glomerular filtration rate
(GFR) and renal blood flow. In the face of a 36% reduction in GFR in
response to the highest dose of ET-1, urinary sodium excretion
(UNaV) increased threefold from
0.57 ± 0.11 to 1.6 ± 0.10 µmol · 100 g
1 · min
1.
Indomethacin (5 mg/kg) decreased basal GFR from 1.2 ± 0.3 ml · 100 g
1 · min
1
to 0.8 ± 0.1 ml · 100 g
1 · min
1
and potentiated the GFR lowering action of ET-1 associated with reductions in UNaV and urine
volume. Cobalt chloride (CoCl2)
and dibromododec-11-enoic acid (DBDD), which diminish CYP450-dependent AA metabolism through different mechanisms, were used to identify CYP450 products mediating the renal functional actions of ET-1. DBDD
(12.5 µg/min) reduced urinary excretion of 20-hydroxyeicosatetraenoic acid from 3.4 ± 0.9 (control) to 1.1 ± 0.6 ng/h and abolished the
negative effects of ET-1 on GFR while decreasing the
diuretic-natriuretic action of ET-1. Similar effects were produced by
CoCl2. Clotrimazole, an inhibitor
of epoxygenase activity, was without effect on ET-1-induced renal
functional changes. Thus the capacity of ET-1 to enhance prostaglandin
production was primarily expressed in terms of positive effects on
renal hemodynamics. In contrast, CYP450 products promoted sodium
excretion despite negative effects on renal hemodynamics.
endothelin-1; renal hemodynamics; dibromododec-11-enoic acid; indomethacin; clotrimazole; cobalt chloride
This article has been cited by other articles:
![]() |
K. Takeuchi, N. Miyata, M. Renic, D. R. Harder, and R. J. Roman Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R84 - R89. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Dos Santos, A. J. Dahly-Vernon, K. M. Hoagland, and R. J. Roman Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R58 - R68. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Rajapakse, R. J. Roman, J. R. Falck, J. J. Oliver, and R. G. Evans Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R181 - R187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Kaide, M.-H. Wang, J.-S. Wang, F. Zhang, V.R. Gopal, J. R. Falck, A. Nasjletti, and M. Laniado-Schwartzman Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries Am J Physiol Renal Physiol, January 1, 2003; 284(1): F51 - F56. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig, M. D. Breyer, and R. M. Breyer Contribution of prostaglandin EP2 receptors to renal microvascular reactivity in mice Am J Physiol Renal Physiol, September 1, 2002; 283(3): F415 - F422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hercule and A. O. Oyekan Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2132 - R2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hercule and A. O. Oyekan Cytochrome P450 omega /omega -1 Hydroxylase-Derived Eicosanoids Contribute to EndothelinA and EndothelinB Receptor-Mediated Vasoconstriction to Endothelin-1 in the Rat Preglomerular Arteriole J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1153 - 1160. [Abstract] [Full Text] |
||||
![]() |
M. Alonso-Galicia, J. R. Falck, K. M. Reddy, and R. J. Roman 20-HETE agonists and antagonists in the renal circulation Am J Physiol Renal Physiol, November 1, 1999; 277(5): F790 - F796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan, K. McAward, J. Conetta, L. Rosenfeld, and J. C. McGiff Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R766 - R775. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Escalante, J. C. McGiff, and A. O. Oyekan Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule Am J Physiol Renal Physiol, January 1, 2002; 282(1): F144 - F150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |